imiquimod has been researched along with Lymphoma, T-Cell, Cutaneous in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| DeSimone, JA; DiLorenzo, A; Lindberg, MR | 1 |
| Bates, SE; Dana, AN; Del Guzzo, CA; Geskin, LJ; Kojadinovic, A; Langhoff, E; Newman, JC; Park, YA; Vinnakota, RR | 1 |
| Huen, AO; Rook, AH | 1 |
| Heald, P; Poligone, B | 1 |
| Junkins-Hopkins, JM; Rook, AH; Suchin, KR | 1 |
| Amerio, P; Benucci, R; Canzona, F; Cavalieri, R; Didona, B; Rienzo, O | 1 |
| Beyeler, M; Burg, G; Conrad, C; Dummer, R; Gilliet, M; Laine, E; Urosevic, M | 1 |
| Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W | 1 |
| Brown, VL; Coutts, I; Stavrakoglou, A | 1 |
2 review(s) available for imiquimod and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma.
Topics: Aminoquinolines; Humans; Imiquimod; Lymphoma, T-Cell, Cutaneous; Oligodeoxyribonucleotides; Quinolinium Compounds; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9; Toll-Like Receptors | 2014 |
Innovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustard.
Topics: Aminoquinolines; Combined Modality Therapy; Cryotherapy; Histone Deacetylase Inhibitors; Humans; Imiquimod; Lasers, Excimer; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Photosensitizing Agents; PUVA Therapy; Stem Cell Transplantation; Therapies, Investigational | 2010 |
1 trial(s) available for imiquimod and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure.
Topics: Adult; Aged; Aged, 80 and over; Agent Orange; Anti-Bacterial Agents; Humans; Imiquimod; Lymphoma, T-Cell, Cutaneous; Middle Aged; Skin Neoplasms; Veterans | 2021 |
6 other study(ies) available for imiquimod and Lymphoma, T-Cell, Cutaneous
| Article | Year |
|---|---|
Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy With Intralesional Injections of 5-Fluorouracil and Topical Imiquimod.
Topics: Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms | 2023 |
Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Biopsy, Needle; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Lymphoma, T-Cell, Cutaneous; Middle Aged; Neoplasm Staging; Skin Neoplasms; Treatment Outcome | 2002 |
Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Cytokines; Follow-Up Studies; Humans; Imiquimod; Interferon-gamma; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Skin Neoplasms | 2004 |
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Clinical Trials as Topic; Dendritic Cells; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Immunohistochemistry; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Microscopy, Confocal; Plasma Cells; Polymerase Chain Reaction; Skin Neoplasms | 2005 |
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Topics: Adult; Aged; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; Imiquimod; Immunosuppressive Agents; Interferons; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; PUVA Therapy; Remission Induction; Skin; Skin Neoplasms; Tacrolimus; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Vincristine | 2003 |
Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Skin Neoplasms; Treatment Outcome | 2007 |